Boehringer Ingelheim
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates in 50 countries and more than 41,500 employees.Since it was founded in 1885, the family-owned company has been committed for 125 years to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. Boehringer Ingelheim is recognised for the excellence of its product pipeline covering therapeutic areas ranging from respiratory, cardiovascular to central nerve system medicines. In recent years, the company also successfully advanced its research in diseases including diabetes and tumors. In 2009, Boehringer Ingelheim posted net sales of EUR 12.7 billion while spending 21% of net sales in its largest business segment, Prescription Medicines, on research and development. For more information, visit www.boehringer-ingelheim.com.
Most Read News
- Abbott to Acquire Action Pharma's Investigational Compound, AP214
- GlaxoSmithKline and Yale University establish drug discovery collaboration
- AstraZeneca and The Medicines Company announce global collaboration in acute ischaemic heart disease
- Abbott's investigational treatment for advanced Parkinson's disease demonstrates positive results
- Serious safety concerns around unlicensed ocular bevacizumab use versus Lucentis
- GSK confirms offer to acquire Human Genome Sciences for US$13.00 per share in cash
- GSK provides update on corporate responsibility commitments in 2011 report
Company Profiles and News
Showcase your Company Profile / News
Pharmaceutical Companies
News in Pictures
Be on top of World Pharma News!
Advertise with us - Download World Pharma News' Media Pack Read more
Abbott Launches New Psoriasisanswers.com Web site
August marks National Psoriasis Awareness Month, an opportunity to raise awareness about psoriasis, a skin disease that affects nearly 7.5 million Americans. For those living with this condition, finding information Read more
AstraZeneca Headquarters, London
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, Read more
Site Roche Basel
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in Read more
Gehry building, Novartis headquarters in Basel, Switzerland
Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving Read more
GSK Corporate HQ
GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better Read more
Sanofi-aventis Group head office
Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: Read more
Boehringer Ingelheim Center, Ingelheim, Germany
The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates in 50 countries and more than 41,500 Read more
Novo Nordisk's corporate headquarters in Bagsværd, Denmark
Headquartered in Denmark, Novo Nordisk is a global healthcare company with 87 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth Read more
Sponsored Video
Business & Industry News
- Pfizer provides topline results from Phase 3 study of Torisel®
- GlaxoSmithKline to fully acquire Cellzome for £61 million
- Bristol-Myers Squibb Foundation Announces $15 Million Expansion of Together on Diabetes® to China and India
- Bristol-Myers Squibb and Tsinghua University Enter Strategic Partnership
- Statistically significant clinical phase III results of Lu AA21004
- GSK commences tender offer to acquire Human Genome Sciences for US $13.00 per share in cash
- Cancer Support Community launches national program to assist patients with cancer
Research & Development News
- In drug-approval race, US FDA ahead of Canada, Europe
- Blood pressure drugs don't protect against colorectal cancer
- Vitamin K2: New hope for Parkinson's patients?
- H1N1 discovery paves way for universal flu vaccine
- Some HDL, or 'good' cholesterol, may not protect against heart disease
- Potential to revive abandoned cancer drug by nanoparticle drug delivery
- Stem cell researchers map new knowledge about insulin production
Conferences & Events News
- 3rd Mastering HR Summit 2012
- ePatient / Health 2.0 - A Key Factor for New and Innovative Business Models for the Life Sciences Industry
- Global E-Health Forum - Hamburg 2011
- Health 2.0 Europe: Over 35 Speakers from 15 Countries Already Confirmed
- 2nd Mastering HR Summit 2011
- Health 2.0 Europe 2011 - Registration is Now Open
- Global E-Health Forum: Designing Personalized Healthcare